DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Goetz M, OʼShaughnessy J, Sledge G. et al.
Abstract GS6-02: The benefit of abemaciclib in prognostic subgroups: an exploratory analysis of combined data from the MONARCH 2 and 3 studies.
Cancer Res 2018;
78: GS6-02-GS06-02
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.